Please use this identifier to cite or link to this item:
Title: Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report
Authors: Bousquet, Jean 
Shamji, Mohamed H.
Anto, Josep M.
Schünemann, Holger J.
Canonica, G. Walter
Jutel, Marek
Del Giacco, Stefano
Zuberbier, Torsten
Pfaar, Oliver
Fonseca, Joao A.
Sousa-Pinto, Bernardo
Klimek, Ludger
Czarlewski, Wienczyslawa
Bedbrook, Anna
Amaral, Rita
Ansotegui, Ignacio J.
Bosnic-Anticevich, Sinthia
Braido, Fulvio
Chaves Loureiro, Cláudia 
Gemicioglu, Bilun
Haahtela, Tari
Kulus, Marek
Kuna, Piotr
Kupczyk, Maciej
Matricardi, Paolo M.
Regateiro, Frederico S. 
Samolinski, Boleslaw
Sofiev, Mikhail
Toppila-Salmi, Sanna
Valiulis, Arunas
Ventura, Maria Teresa
Barbara, Cristina
Bergmann, Karl C.
Bewick, Michael
Blain, Hubert
Bonini, Matteo
Boulet, Louis-Philippe
Bourret, Rodolphe
Brusselle, Guy
Brussino, Luisa
Buhl, Roland
Cardona, Victoria
Casale, Thomas
Cecchi, Lorenzo
Charpin, Denis
Cherrez-Ojeda, Ivan
Chu, Derek K.
Cingi, Cemal
Costa, Elisio M.
Cruz, Alvaro A.
Devillier, Philippe
Dramburg, Stephanie
Fokkens, Wytske J.
Gotua, Maia
Heffler, Enrico
Ispayeva, Zhanat
Ivancevich, Juan Carlos
Joos, Guy
Kaidashev, Igor
Kraxner, Helga
Kvedariene, Violeta
Larenas-Linnemann, Désirée E.
Laune, Daniel
Lourenço, Olga
Louis, Renaud
Makela, Mika
Makris, Michael
Maurer, Marcus
Melén, Erik
Micheli, Yann
Morais-Almeida, Mario
Mullol, Joaquim
Niedoszytko, Marek
O'Hehir, Robyn
Okamoto, Yoshitaka
Olze, Heidi
Papadopoulos, Nikolaos G.
Papi, Alberto
Patella, Vincenzo
Pétré, Benoit
Pham-Thi, Nhân
Puggioni, Francesca
Quirce, Santiago
Roche, Nicolas
Rouadi, Philip W.
Sá-Sousa, Ana
Sagara, Hironori
Sastre, Joaquin
Scichilone, Nicola
Sheikh, Aziz
Sova, Milan
Suppli Ulrik, Charlotte
Taborda-Barata, Luis
Todo-Bom, Ana 
Torres, Maria J.
Tsiligianni, Ioanna
Usmani, Omar S.
Valovirta, Erkka
Vasankari, Tuula
Vieira, Rafael José
Wallace, Dana
Waserman, Susan
Zidarn, Mihaela
Yorgancioglu, Arzu
Zhang, Luo
Chivato, Tomas
Ollert, Markus
Keywords: apps; ARIA; digital health; EAACI; rhinitis
Issue Date: Jul-2023
Publisher: Wiley-Blackwell
Serial title, monograph or event: Allergy: European Journal of Allergy and Clinical Immunology
Volume: 78
Issue: 7
Abstract: Biomarkers for the diagnosis, treatment and follow-up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There are no validated biomarkers in rhinitis or allergen immunotherapy (AIT) that can be used in clinical practice. The digital transformation of health and health care (including mHealth) places the patient at the center of the health system and is likely to optimize the practice of allergy. Allergic Rhinitis and its Impact on Asthma (ARIA) and EAACI (European Academy of Allergy and Clinical Immunology) developed a Task Force aimed at proposing patient-reported outcome measures (PROMs) as digital biomarkers that can be easily used for different purposes in rhinitis and asthma. It first defined control digital biomarkers that should make a bridge between clinical practice, randomized controlled trials, observational real-life studies and allergen challenges. Using the MASK-air app as a model, a daily electronic combined symptom-medication score for allergic diseases (CSMS) or for asthma (e-DASTHMA), combined with a monthly control questionnaire, was embedded in a strategy similar to the diabetes approach for disease control. To mimic real-life, it secondly proposed quality-of-life digital biomarkers including daily EQ-5D visual analogue scales and the bi-weekly RhinAsthma Patient Perspective (RAAP). The potential implications for the management of allergic respiratory diseases were proposed.
ISSN: 0105-4538
DOI: 10.1111/all.15740
Rights: openAccess
Appears in Collections:I&D ICBR - Artigos em Revistas Internacionais
FMUC Medicina - Artigos em Revistas Internacionais

Show full item record

Page view(s)

checked on Feb 20, 2024


checked on Feb 20, 2024

Google ScholarTM




This item is licensed under a Creative Commons License Creative Commons